NEWSMAX @NEWSMAX
NEW STUDY: The omicron-adapted COVID-19 vaccine booster developed by Pfizer and BioNTech sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab's real-world effectiveness. https://t.co/pFrTtwkpNO — PolitiTweet.org